Meridian Bioscience Analysis
| VIVODelisted Stock | USD 33.97 0.00 0.00% |
Meridian Bioscience is overvalued with Real Value of 28.28 and Hype Value of 33.97. The main objective of Meridian Bioscience delisted stock analysis is to determine its intrinsic value, which is an estimate of what Meridian Bioscience is worth, separate from its market price. There are two main types of Meridian Bioscience's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Meridian Bioscience's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Meridian Bioscience's stock to identify patterns and trends that may indicate its future price movements.
The Meridian Bioscience stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Meridian Bioscience is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Meridian Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Meridian Bioscience's ongoing operational relationships across important fundamental and technical indicators.
Meridian |
Meridian Stock Analysis Notes
About 91.0% of the company outstanding shares are owned by institutional investors. The book value of Meridian Bioscience was at this time reported as 8.41. The company has Price/Earnings To Growth (PEG) ratio of 1.33. Meridian Bioscience last dividend was issued on the 1st of February 2019. The entity had 3:2 split on the 14th of May 2007. Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. Meridian Bioscience, Inc. was incorporated in 1976 and is headquartered in Cincinnati, Ohio. Meridian Bioscience operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 702 people. For more information please call John Kraeutler at 513 271 3700 or visit https://www.meridianbioscience.com.Meridian Bioscience Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Meridian Bioscience's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Meridian Bioscience or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Meridian Bioscience is not yet fully synchronised with the market data | |
| Meridian Bioscience has a very high chance of going through financial distress in the upcoming years | |
| Over 91.0% of the company outstanding shares are owned by institutional investors |
Meridian Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.49 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Meridian Bioscience's market, we take the total number of its shares issued and multiply it by Meridian Bioscience's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Meridian Profitablity
Meridian Bioscience's profitability indicators refer to fundamental financial ratios that showcase Meridian Bioscience's ability to generate income relative to its revenue or operating costs. If, let's say, Meridian Bioscience is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Meridian Bioscience's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Meridian Bioscience's profitability requires more research than a typical breakdown of Meridian Bioscience's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.13 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.23 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.23. Meridian Bioscience Predictive Daily Indicators
Meridian Bioscience intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Meridian Bioscience stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About Meridian Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Meridian Bioscience prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Meridian shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Meridian Bioscience. By using and applying Meridian Stock analysis, traders can create a robust methodology for identifying Meridian entry and exit points for their positions.
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. Meridian Bioscience, Inc. was incorporated in 1976 and is headquartered in Cincinnati, Ohio. Meridian Bioscience operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 702 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Meridian Bioscience to your portfolios without increasing risk or reducing expected return.Did you try this?
Run ETFs Now
ETFsFind actively traded Exchange Traded Funds (ETF) from around the world |
| All Next | Launch Module |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Meridian Stock
If you are still planning to invest in Meridian Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Meridian Bioscience's history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Transaction History View history of all your transactions and understand their impact on performance |